Drug Shortage Report for AURO-ALENDRONATE

Last updated on 2020-03-14 History
Report ID 47443
Drug Identification Number 02388545
Brand name AURO-ALENDRONATE
Common or Proper name Alendronic Acid
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-09-04
Estimated end date
Actual end date 2020-03-13
Shortage status Resolved
Updated date 2020-03-14
Company comments
Health Canada comments
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2020-03-14 English Compare
v19 2020-03-13 French Compare
v18 2020-03-13 English Compare
v17 2020-03-13 French Compare
v16 2020-03-13 English Compare
v15 2020-02-13 French Compare
v14 2020-02-13 English Compare
v13 2019-10-24 French Compare
v12 2019-10-24 English Compare
v11 2019-10-11 French Compare
v10 2019-10-11 English Compare
v9 2019-10-01 French Compare
v8 2019-10-01 English Compare
v7 2019-10-01 French Compare
v6 2019-10-01 English Compare
v5 2019-09-05 French Compare
v4 2019-09-05 English Compare
v3 2019-09-05 French Compare
v2 2019-09-05 English Compare
v1 2018-04-30 English Compare